M. Mattei et al., CD4-8- T-CELLS INCREASE IN MRL LPR MICE TREATED WITH THYMIC FACTORS/, International journal of immunopharmacology, 16(8), 1994, pp. 651-658
The in vivo effect of thymic factors on immature lymphocytes was analy
sed in MRL/lpr mice. This strain carries a genetic defect that causes
during their life cycle a block of T-cell differentiation and abnormal
proliferation of CD4(-)8(-) (double-negative, DN) T-lymphocytes. In v
ivo administration of four preparations of thymic factors, thymopentin
(TP-1), thymopoietin (TP-5), thymolymphotropin (TLT), and thymomoduli
n (TMD) into young (2-month-old) MRL/lpr mice induced a significant in
crease of DN T-cells both in the thymus and in the peripheral lymph no
des, with a concomitant decrease of double-positive (DP) T-cells in th
e thymus and of single-positive (SP) T-cells in the lymph nodes. The l
evel of DNA fragmentation measured as propidium iodide fluorescence wa
s increased in the thymus population of young mice and in the lymph no
de population of old mice treated with TLT. SCID mice transplanted wit
h lymph node cells from MRL/lpr donors (MRL-->SCID) developed graft ve
rsus host (GVH) reaction due to the activation of MRL CD8(+) alloreact
ive T-cells. This model was used to analyse the effect of TMD/TLT in v
ivo on MRL cell proliferation and expansion; in fact, spleen cells fro
m MRL-->SCID mice after treatment with TMD/TLT showed an increased cel
l proliferation, and an expansion of DN T-cells with a concomitant dec
rease of SP cells (both CD4(+) and CD8(+) cells). Decreased SP cell nu
mbers in this context could explain why TMD/TLT treatment of SCID mice
engrafted with MRL cells increased their survival compared to untreat
ed MRL-->SCID mice.